SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-016819
Filing Date
2024-01-26
Accepted
2024-01-26 16:58:24
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d750134ds3.htm S-3 184471
2 EX-5.1 d750134dex51.htm EX-5.1 11647
3 EX-23.1 d750134dex231.htm EX-23.1 1293
4 EX-FILING FEES d750134dexfilingfees.htm EX-FILING FEES 16263
5 GRAPHIC g750134g0126075643673.jpg GRAPHIC 3252
6 GRAPHIC g750134g0126075644083.jpg GRAPHIC 1414
7 GRAPHIC g750134g13u34.jpg GRAPHIC 47918
  Complete submission text file 0001193125-24-016819.txt   287636
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276719 | Film No.: 24568722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)